To get a sense of who is truly in control of Alcon Inc. ( VTX:ALC ), it is important to understand the ownership structure of ...

On Thursday, Redburn-Atlantic revised its rating on Alcon Inc. (NYSE:ALC:SW) (NYSE: ALC), lifting the stock from Sell to Neutral and increasing the price target to CHF78.00 from CHF68.00.

On Thursday, Redburn-Atlantic revised its rating on Alcon Inc. (NYSE:ALC:SW) (NYSE: ALC), lifting the stock from Sell to Neutral and increasing the price target to CHF78.00 from CHF68.00. The upgrade ...

Alcon Inc. ALC benefits from strong market share gains. The company’s broad pipeline and focus on research and innovation are impressive. Yet, challenging international market with geopolitical ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Alcon Inc. (NYSE:ALC), a global leader in eye care products, finds itself at a critical juncture as it navigates a competitive landscape while leveraging its robust product pipeline. The company ...

Alcon, Inc. (NYSE: ALC) delivered core earnings per share of 74 cents in the second quarter of 2024, up 7.2% from the year-ago quarter's figure (up 15% at the constant exchange rate or CER).

Begin your TipRanks Premium journey today. Alcon (ALC) Company Description: Alcon Inc. is a medical company which is specialized in eye care products. The company develops, manufactures ...